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Comparative Observations on Inorganic
and Organic Lead Neurotoxicity
by M. Anthony Verity*
Environmental and occupational exposure to lead still generates concern, and recent studies have focused
such concern on the role ofbody burden of lead during the fetal/neonatal period, especially in the genesis
ofdisturbed central nervous system development. This discussion provides some comparative observations on
the neurotoxicity of inorganic and organic lead species. The characteristic acute, predominantly cerebellar
encephalopathy associated with neonatal high leadexposure contrasts to thesubtle, axo-dendritic disorganization
shown to be associated with low-level neonatal inorganic Pb2+ exposure. There is a preferential involvement
ofthe hippocampus in both low-level inorganic Pb2+ and organolead exposure, and the clinical syndromes of
irritability, hyperactivity, aggression, and seizures are common features ofdisturbed hippocampal function.
Neurotransmitter system abnormalities have been described with inorganic Pb2+, but recent attention has
focused on the abnormalities in glutamate, dopamnine, and/or 'y-aminoboutyric acid (GABA) uptake, efflux,
and metabolism. Abnonnalities ofGABA and glutamate metabolism are alsofoundwith the organolead species.
While the pathogenesis is still unclear, the interactive role ofPb2+ on mitochondrial energy metabolism, Ca2+
uptake, intracellular CaF+ homeostasis, and neurotransmitter influx/efflux is considered. Consideration is given
to low-dose inorganic Pb2+and organolead effects on mitochondrial and/orplasmalemmel membranes inducing
either Cl-/OH- antiport-linked depolarization, inhibition of intracellular ATP biosynthesis and transduction,
and/or abnormalities induced due to the preferential affinity ofPb2+ for intracellular Ca2+-cytoplasmic pro-
teins, e.g., calmodulin. Testable hypotheses are presented that mayprovide an understandingofthe pathogenesis
underlying dystrophic neuronal development under the influence of inorganic or organolead intoxication.
Prologue
"Recommendation 9-2: Emphasis and encouragement
should be given to studies on mechanisms involved in the
search for, and analysis of, appropriate chemically-induced
single pathologic processes ...in contrast to placing emphasis
on research onexperimental diseases in which multiple types
of tissue damage are induced."
"Recommendation 14-52: ... [chemical agents] special
attention shouldbe given to the evaluation ofeffects on the
fetus, .iifnt... .uniquely vuinerable to environmental toxicants
which damage the CNS."
(Report of Special Task Force for Research
Planning in Environmental Health Science,
submitted to Dr. David P. Rall, Director,
National Institute of Environmental Health Sciences,
December 21, 1976)
Introduction
Lead exposure from environmental and occupational
sources still remains of great concern. Although low-level
amounts oflead are present in man and all living organisms,
indices of sublethal health effects and the nature of lead
speciation are problems ofrecurrent concern. As indicated
in this conference (1), lead toxicity in childhood was thought
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to be without residual effect in nonlethal cases; a miscon-
ception corrected by the studies of Randolph Byers who
asserted in 1943 thatlead notonlykilled cells butinterfered
with normal neuronal development. While the inorganic com-
pounds oflead are recognized neurotoxicants in human and
animal models, alkyl derivatives of lead are equipotent on
a dosage basis and equally neurotoxic, comparable to
observations on lead toxicity in bacteria and fungi (2).
This discussion provides some comparative observations
betweeninorganic and organic lead neurotoxicity. Concerns
referable to environmental source, routes of transport,
absorption ofthe different lead species, partitioning, pharma-
cokinetic studies, and ancillary factors affecting the suscep-
tibility of organ systems, in particular, the central nervous
system, to lead toxicity will not be discussed. Attention will
be focused on comparing the clinical and morphologic pat-
terns ofneurotoxic injury, comparing the effect ofdifferent
lead species on neurotransmitter metabolism in defined
neural systems, andproposingmechanisms ofneuronalinjury
induced by the lead compounds of interest. The reader is
referred to otherreviews detailingthe neurobehavioral con-
sequences of inorganic lead exposure (3,4).
Clinical Patterns of Injury
Inorganic lead (Pb2+) produces a clinically definable
encephalopathy and neuropathy dependent upon age, route
ofadministration, and dose. The neonatal developing brainM. A. VERITY
is particularly sensitive to the effects oflead poisoning (5-7).
Acute, high-dose lead administration in the neonate produces
aclassic clinicopathologic complex in humanand experimental
animals. Acute cerebral and cerebellar edema with hemor-
rhage are features of acute high-dose administration with
the appropriate clinical manifestations of acute encephalo-
pathy and seizures. The neuropathologic findings, while
variable, are considered secondary to a proximate micro-
vascularpermeability change leading to red cellleakage, sub-
acute endothelial proliferation, endothelial cell necrosis,
microthrombosis, and perivascular periodic acid-Schiff (PAS)-
positive exudation (8-11).
While all the steps in the pathogenesis of acute Pb2+
encephalopathy are still unclear, a likely hypothesis is based
upon the encephalopathy being secondary to a Pb2+-
induced vasculopathy. A direct toxic effect of Pb2+ on neu-
rons is still equivocal. The cause ofthe apparent preferential
sensitivity of the neonatal brain compared to adult is still
unanswered but may be a reflection of the primitive, non-
coupled development between the neonatal endothelial cell
and astrocyte composing the blood-brain barrier, known to
be developmentally immature during early brain develop-
ment. Inthis hypothesis, itis proposed thatthe mature astro-
cyte would provide a detoxification sink for removal of
endothelial lead, thereby preventing excessive endothelial
Pb2+ uptake, mitochondrial damage, and initiation of endo-
thelial necrosis.
The neuroclinical and pathologic changes associated with
low-level, chronic lead exposure are well documented. There
is a high incidence of irritability, hyperactivity, retardation
ofnormal development, seizures, and psychomotor distur-
bance. Lead exposure is associated with hyperactivity, in
turn a known risk factor for antisocial and aggressive
behavior. Unfortunately, clear-cut neuropathologic findings
associated with low-level lead exposure in humans are ill-
described, and animal models have revealed confusing
results. The neuropathologic changes, if true, have been
detailed through morphometric analysis and have revealed
alterations in dendritic arborization and density of synaptic
complexes in the cerebral cortex (12,13), a decrease inhippo-
campal pyramidal neuron spine density (14), reduction in den-
tate granule neuron dendritic field (15), decreased mossy
fiber terminal proliferation in hippocampus (16,17), and abnor-
mal dendritic branching ofcerebellar Purkinje cells (18). In
this latter study, the authors precluded the role of under-
nutrition incontribufing to the dendritic abnormality and also
demonstrated occurrence of these changes at blood levels
insufficient to produce overt clinical toxicity. The described
reduction in hippocampal development characterized by dys-
plasia in axonal and dendritic development ofthe hippocampal
dentate granule cells would suggest a serious disturbance
ofnormal hippocampal functioning. The reported behavioral
changes in postnatally lead-exposed animals includes recur-
rent seizures (19), impairment in motor coordination (20),
and increased aggressiveness (21).
The clinical syndrome causedby organolead, e.g., triethyl
lead (TEL), the principal neurotoxic metabolite oftetraethyl
lead, evolves through three phases: an initial phase of
lethagy followed by tremors, hyperexcitability, hypermotility,
and aggressionleading finally to convulsions, ataxia, paralysis,
and death (22). As with inorganic lead, acute and chronic
syndromes may be identified. A single high dose (20 mg/kg
TEL) produces a mixture of chromatolytic and necrotic
neuronal changes, especially in the hippocampus and
associated regions ofthe limbic system. Chronic, sublethal
dosing also selectively produces a sporadic loss ofneurons
in the anterior pyriform cortex and hippocampus and effects
on myelination in the developing brain (23,24). Of note is
the relative sensitivity of the young adult animal to induc-
tion ofthis pathology compared to resistance ofthe suckling
neonate. This age difference in dose response is in contrast
to the inorganic lead model.
Organolead toxicity produces a restricted pattern ofneural
damage involving primarily the limbic forebrain and frontal
cortex (25,26). Trialkyl leads produce a variety of neuro-
behavioral effects that resemble those induced by experi-
mental damage to the limbic forebrain. The limbic system
is thought to participate in the modulation ofbehavioral reac-
tivity, motivation, learning, and memory (27). As previously
mentioned, the neurotoxicity induced by the organoleads
resembles the pattern ofneurobehavioral deficits observed
following limbic system damage. Notable is the similarity
with perinatal exposure to inorganic Pb2+. Table 1 summa-
rizes some ofthe similarities between the neuropathologic
and neurobehavioral effects of neonatal inorganic Pb2+ and
adult organolead exposure. Table 2 identifies observations
pertaining to changes in the limbic system induced by inor-
ganic and organic lead species. Recent observations sug-
gestthatthe organoleads mightproduce some oftheirbehav-
ioral effects by disrupting benzodiazepine processes in the
limbic forebrain known to modulate reactivity to aversive
environmental stimuli (4). Our in vitro synaptosomal studies
(28,29) have revealed a relative preferential sensitivity of
-y-aminobutyric acid (GABA) uptake to triethyl lead due to
inhibition of GABA binding to the uptake site in synaptic
membranes.
Table 1. Neuropathology of inorganic and organic lead.
Pathology Pb2+ Organic lead
Endothelial damage Neonatal No
Reversible astrocytosis Yes No
Hypomyelination 20 to axonal Post-translational
hypoplasia defect
Cerebeluar necrosis Neonatal ? In adults
Hippocampal necrosis No Adult
Decreased synaptogenesis Yes Yes
in hippocampus
Table 2. Limbic system as target for lead neurotoxicity.
Observation Reference
High endogenous lead (70,71)
Decreased spine density in CAl (14)
Decreased synaptogenesis (15,16)
Decreased ACh turnover (72)
Impaired spatial learning (73,74)
Increased seizure (4,31)
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Comparative Studies of Brain
Neurochemistry: Lead and Organolead
While the involvement ofvarious neurotransmitter systems
(e.g., cholinergic, noradrenergic, GABAergic, and dopa-
minergic) have been proposed (30,31), most attention has
been devoted to examining the interaction of the inorganic
or organolead species with glutamate and GABA. Early
studies by Bondy et al. (32) compared the effect oforganic
and inorganic lead on high-affinity neurotransmitter transport
in adult mouse brain homogenates. The uptake and release
of dopamine was especially affected by organolead at
10-8 M; inorganic Pb2+ was several orders of magnitude
less toxic. However, the IDW for glutamate, dopamine, and
GABA was found at approximately 10-6 M, suggesting a
selective vulnerability ofdopaminergic neurons to lead. Such
selective vulnerability is also suggested by the nature ofthe
neurological deficit characterized as fine tremor, hyperactiv-
ity, and irritability, stigmata of dopaminergic function. The
uptake studies were performed following 5 min incubation,
thereby avoiding the problem of depleted ATP caused by
uncoupling of synaptosomal oxidative phosphorylation
(28,33). It is likely, therefore, that the selective inhibition
of uptake of dopamine > GABA > glutamate is a reflec-
tion oforganolead interaction with specific uptake protein(s)
within the membrane or with the immediate membrane envi-
ronment as recently suggested for the GABA uptake site
in the synaptic membrane (29). The lack ofinteraction with
inorganic Pb2+ would appear to preclude a role for inor-
ganic lead-induced deficits in neurotransmitter movement
atlow blood level concentrations in an understanding ofthe
pathogenesis of lead toxicity.
Attempts have been made to link the neurobehavioral and
physiological effects oflow-dose, chronic Pb2+ exposure to
dopaminergic activity (34-36). Particularly relevant in this
respect is the observation by (37), who demonstrated that
low-dose Pb2+ exposure of the developing rat central ner-
vous system caused a permanent increase in lithium-induced
polydipsia (LIP). Subsequent studies showed that the LIP
response was dependent on an intact nigrostriatal dopamine
system (38). It is possible that the nigrostriatal pathway,
although an integral part ofthe neural circuit mediating LIP,
may not be the proximate site of Pb2+ interaction. For in-
stance, the angiotensin-2 receptors present in the third ven-
tricle (and hypothalamus) may be the primary locus of
Pb2+ interaction. The limbic system serves as an interface
betweenthe hypothalamus andneocortex, and anearly onset
developmental abnormality in dopaminergic neuron matura-
tion may account for the apparent limbic system-mediated
behavioral abnormalities.
The effects of lead on mitochondrial energy metabolism
are potentially important in the pathogenesis ofrat and human
lead encephalopathy. Studies with inorganic Pb2+ have
revealed effects onmitochondrial partal reactions significantly
different fromorganolead. In vivo (39) and in vitro (40) effects
of inorganic Pb2+ on immature rat brain mitochondrial res-
piration are comparable. With all substrates, low Pb2+ con-
centrations produced an increase in respiration. Higher
concentrations produced an inhibition ofrespiration, inhibi-
tion of ADP-dependent (stage 3) respiration, decrease in
respiratory control ratio (41), and apparent dependence on
extramitochondrial [PO3-] and [Mg2+]. Such effects, in
vitro, were evident at approximately 1 to 5 AtM lead con-
centrations. The Pb2+-induced increase in respiration was
shown to be associated with inward transport of Pb2+ by
beef-heart mitochondria (42), an energy-dependent process
with characteristics in common with mitochondrial Ca2+
accumulation (43). Mitochondrial Ca2+ uptake into mito-
chondria is competitively inhibited by Pb2+ at a lower con-
centration than the inhibition of respiration (44).
The possibility that disturbances of intracellular Ca2+
homeostasis may serve as a common pathway forneuronal
injury allows for speculation on the possible mechanism
underlying the acute cerebellar encephalopathy associated
with Pb2+ exposure in immature rats and humans. The de-
scribed effects on mitochondria will lead to a net decrease
of mitochondrial Ca2+ uptake, increased mitochondrial Ca2+
effiux, increased mobilization of Ca2+ from endoplasmic
reticulum, and interference with the ATP-driven Ca2+-
ATPase (45) located in the plasmalemma. It is possible,
therefore, that the acute endothelial injury recognized as
an early event in acute cerebellar Pb2+ encephalopathy is
dependent on the abnormal mobilization of intracellular
Ca2+ with a resultant increase of free cytosolic Ca2+. This
scenario does not preclude the idea that Pb2+ may also act
as a calcium-mimetic agent, somewhat similar to Hg2+
(46). In either event, elevated intracellular Ca2+ appears to
play an important role in the mechanism of cell death in
certain pathologic conditions (47-49).
The organolead compounds are also well-documented tox-
ins ofenergy metabolism in isolated mitochondria (50-54).
While a potential relationship exists between the organolead-
induced lesion in energy transduction and synaptic function,
especially neurotransmitter reuptake and release, our studies
(28) have not demonstrated such coupling for GABA uptake.
Moreover, (33) confirmed the Cl--dependent uncoupling of
oxidative phosphorylation bytriethyllead (28) and increased
cytosolic free Ca2+ in cerebro-cortical synaptosomes. Such
Ca2+ was derived from the intraterminal mitochondria
subsequent to the uncoupling ofmitochondrial ATP synthesis
from oxidation. In summary, the neurotoxicity oforganolead
suggests a more acute mechanism underlying the patho-
genesis of cellular injury. In particular, the dependence on
Cl- and the changes in membrane depolarization coupled
with the failure ofbioenergetic potential and increased intra-
cellular Ca2+ strongly suggest a mechanism of neuronal
death analogous to the mechanisms ofexcitotoxic cell injury
(55).
Recent findings indicate that inorganic Pb2+ can substi-
tute for Ca2+ with certain intracellular Ca2+-binding pro-
teins (Table 3). Such observations suggest a variety of
hypotheses for understanding the molecular basis ofits toxic
action, especially in reference to both the acute and low-
level, chronic exposure models of neurotoxicity. Pb2+ inter-
acts with calmoduiin with an affinity at least equal to that
for Ca2+ (56). Lead may substitute for Ca2+ in a variety of
Ca2+-dependent processes. Many of these processes are
related to Ca2+ as a cytoplasmic second messenger, there-
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Table 3. Inorganic Pb2+ may replace Ca2l in select intracellular
mechanisms (the Ca2+-mimetic effect of Pb2+).
Calmodulin-stimulated phosphodiesterase
Ca-dependent K+ permeability (RBCs)
Stimulates brain protein kinase C
Mitochondrial uptake (respiration dependent)
Ca pump ATPase (RBCs)
by coupling Ca2+ to specific effector mechanisms. Other
interactions are not calmodulin dependent, for instance
Ca2+-dependent exocytosis and Ca2+-dependent K+
permeability in the plasma membrane.
We have discussed the role oflead/calcium in mitochon-
drialbioenergetics, but ofimmediate interest to this discus-
sion is the recent recognition that low concentrations of
Pb2+ may stimulate brain protein kinase C (57). Protein
kinase C is a Ca2+-and phospholipid-dependent enzyme
known to mediate cellular proliferation and differentiation
via phosphorylation ofregulatory proteins (58). Ourinterest
in this reaction is twofold: first, the remarkable heavy metal
specificity to Pb2+ and sensitivity at 10-10 M when con-
trasted to CaCl2. Second, the effective intracellular con-
centration of 10-10 M would be reached following blood
concentrations ofbetween 5 and 10 ,ug/100 mL, represent-
ing approximately 10-6 M. Hence, the unique and marked
sensitivity of protein kinase C to Pb2+ represents a poten-
tial interaction at low, nonsymptomatic, chronic Pb2+ con-
centrations, especially in the developing nervous system.
Continued bioelectric activity influences the survival of
nerve cells during their early development (59,60). Prolonga-
tion ofneuronal survival in culture is dependent on chronic
depolarization usually maintained by high extracellular K+
(61-63). How depolarization affects neuronal survival and
differentiation is unclear but increased [K+]e is known to
activate voltage-sensitive Ca2+ channels (64), and Ca2+
entry has been implicated in the developmental effects of
depolarization on neuronal survival and differentiation. Pb2+
uptake may occur via calcium channels (65). Simons and
Pocock (65), using chromaffin cels, demonstrated an approx-
imate 5-fold stimulation of Pb2+ uptake following K+ de-
polarization, which was antagonized by external Ca2+ inhib-
ited by Ca2+ channel blockers and stimulated by the Ca2+
agonist BAY K8644 (Table 4).
More specifically, Gabo et al. (66) studied the role of
depolrization onthe survival and differentiation ofcerebellar
granule cells in culture and found that neuronal survival was
not influenced by the bioelectric activity but was critically
dependent on the depolarization-induced transmembrane
Ca2+ flux (Table 5). Moreover, inhibitors of calmodulin
blocked the differentiating effect of K+-induced depolariza-
tion. These observations linkthe survival and differentiation
of neurons to a constant depolarization-coupled Ca2+ flux,
Table 4. Pb2+ uptake occurs via Ca2, channels (65).
Stimulation by K+ depolarization
Antagonized by Ca2+
Inhibited by Ca2+ channel blocker, D-600 (Ko.5 = 0.4 IM)
Stimulated by Ca agonist BAY K8644
Table 5. Depolarization is coupled to survival
and differentiation of neurons in culture (66).
High [K +] in medium
Need for depolarization-induced transmembrane flux of Ca2+
(voltage-dependent Ca2+ influx)
Ca2+ agonists could substitute for low [K+]
Calmodulin inhibitors blocked neuronal survival and maturation
Table 6. Postulated mechanism of Pb2+-induced encephalopathy.
Type Mechanism
Acute Uptake via Ca2+ channel
Increased affinity for Ca2+-modulated systems
Block Ca2+ uptake into mitochondria and endoplasmic
reticulum
Increased cytoplasmic [Ca2+]
Ca2`-mediated cell death
Chronic Pb2+ uptake via Ca2+ channel (voltage dependent)
Requirement for depolarization in neuronal differentiation
Activation of protein kinase C
Modification of calmodulin-dependent processes
Cytoskeletal protein post-translation modifications
Dysplastic neurite proliferation
itself transduced by a calmodulin-dependent event(s) to
neuronal differentiation, especially neurite outgrowth, speci-
fication, and stabilization ofsynaptic contacts. A critical deter-
minant ofneurite organization is microtubule assemblyregu-
lated by the calmodulin-Ca2+ complex (67-69).
How then can we explain the apparent differences inbrain
injury resulting from acute contrasted to low-level, chronic
inorganic Pb2+ intoxication? In the acute model we may
propose that Pb2+ uptake via Ca2+ channels (voltage sensi-
tive and insensitive) into immature capillary endothelial cells
will triggerintracellular processes leading to defective mito-
chondrial bioenergetics and mobilization of intracellular
Ca2+, leading to cellular (endothelial) necrosis. In contrast,
low-level, chronic Pb2+ exposure is manifested by subtle
defects in axodendritic architecture andneurite organization
secondary to defective cytoskeletal organization. The need
forcontinued depolarization inneuronal developmentislinked
to stimulation of Pb2+ uptake and the resultant high-affinity
binding to Ca2+ binding proteins, especially calmodulin.
The abnormal and possibly prolonged activation of
calmodulin-dependent processes, especially the activation
of protein kinase C, will lead to distorted transmembrane
signalling and defective neuronal differentiation (Table 6).
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